日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancer

CREB5 调控干细胞样转录程序，从而促进前列腺癌的肿瘤进展

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.28826
Makovec, Allison; Phoenix, John T; Bergom, Hannah E; Boytim, Ella; Gustafson, Ava P; Deacon, Aiden; Tape, Sydney; Ali, Atef; Ludwig, Megan; Pitzen, Samuel P; Moline, David; Richter, Camden; Longie, Hudson; Su, Mei-Chi; Jena, Sampreeti; Likasitwatanakul, Pornlada; Drake, Justin M; Huang, R Stephanie; Hahn, William C; Rennhack, Jonathan P; Dehm, Scott M; Kregel, Steven; Antonarakis, Emmanuel S; Hwang, Justin
肿瘤
发育与干细胞
肿瘤免疫
信号转导
CREB
干细胞
细胞生物学
前列腺癌
发表日期：2026
文献求助 收藏

Author Correction: CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer

作者更正：CREB5促进基底样乳腺癌的肿瘤发生并上调可药物靶向的细胞表面模式

期刊:npj Precision Oncology
影响因子:8
doi:10.1038/s41698-025-01168-1
Makovec, Allison; Boytim, Ella; Gustafson, Ava; Ludwig, Megan; Wang, Liangjun; Ali, Atef; Ishani, Khalid; Luo, Christine; Bergom, Hannah E; John, Emily; Tape, Sydney; Kellen, Samuel; Deacon, Aiden; Dewji, Fatemah Iman; Richter, Camden; Cookle, Lauren; Moline, David; Rennhack, Jonathan P; Drake, Justin M; Antonarakis, Emmanuel S; Largaespada, David A; Ostrander, Julie H; Hwang, Justin
乳腺癌
肿瘤
CREB
细胞生物学
肿瘤免疫
发表日期：2025
文献求助 收藏

CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer

CREB5促进基底样乳腺癌的肿瘤发生并上调可药物靶向的细胞表面模式

期刊:npj Precision Oncology
影响因子:8
doi:10.1038/s41698-025-01051-z
Makovec, Allison; Boytim, Ella; Gustafson, Ava; Ludwig, Megan; Wang, Liangjun; Ali, Atef; Ishani, Khalid; Luo, Christine; Bergom, Hannah E; John, Emily; Tape, Sydney; Kellen, Samuel; Deacon, Aiden; Dewji, Fatemah Iman; Richter, Camden; Cookle, Lauren; Moline, David; Rennhack, Jonathan P; Drake, Justin M; Antonarakis, Emmanuel S; Largaespada, David A; Ostrander, Julie H; Hwang, Justin
肿瘤
肿瘤免疫
乳腺癌
CREB
细胞生物学
发表日期：2025
文献求助 收藏

Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes.

携带 BRCA2 突变的转移性前列腺癌与携带 ATM 突变的转移性前列腺癌表现出不同的分子特征和临床结果

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-3394
Hwang Justin, Shi Xiaolei, Elliott Andrew, Arnoff Taylor E, McGrath Julie, Xiu Joanne, Walker Phillip, Bergom Hannah E, Day Abderrahman, Ahmed Shihab, Tape Sydney, Makovec Allison, Ali Atef, Shaker Rami M, Toye Eamon, Passow Rachel, Lozada John R, Wang Jinhua, Lou Emil, Mouw Kent W, Carneiro Benedito A, Heath Elisabeth I, McKay Rana R, Korn W Michael, Nabhan Chadi, Ryan Charles J, Antonarakis Emmanuel S
肿瘤
前列腺癌
发表日期：2023
文献求助 收藏

ALAN is a computational approach that interprets genomic findings in the context of tumor ecosystems

ALAN是一种计算方法，它在肿瘤生态系统的背景下解释基因组学发现。

期刊:Communications Biology
影响因子:5.1
doi:10.1038/s42003-023-04795-1
Bergom, Hannah E; Shabaneh, Ashraf; Day, Abderrahman; Ali, Atef; Boytim, Ella; Tape, Sydney; Lozada, John R; Shi, Xiaolei; Kerkvliet, Carlos Perez; McSweeney, Sean; Pitzen, Samuel P; Ludwig, Megan; Antonarakis, Emmanuel S; Drake, Justin M; Dehm, Scott M; Ryan, Charles J; Wang, Jinhua; Hwang, Justin
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏